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 Summary
The first case of a female neonate born from an in vitro fertilization with embryo transfer (IVF-ET) and 
intracytoplasmic sperm injection (ICSI) (IVF-ET (ICSI) with two histologically different tumours (craniopharyngioma 
and hepatoblastoma) is described. Anti-neoplasmatic therapy was abandoned due to the significant extent of 
the disease (craniopharyngioma, 15×12 cm in diameter with active internal hydrocephalus; and right liver lobe 
hepatoblastoma, 5 cm in diameter) and the severely impaired general condition of the neonate. The neonate died 
on the 30th day of life due to cerebellar and brainstem herniation, followed by circulatory and respiratory failure. 
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 Streszczenie
Przedstawiono Opisano pierwszy przypadek noworodka urodzonego w następstwie zapłodnienia pozaustrojowego 
(IVF-ET ICSI) z dwoma różnymi histologicznie guzami nowotworowymi (craniopharyngioma and hepatoblastoma). 
Ze względu na stopień zaawansowania choroby (craniopharyngioma, 15x12 cm z aktywnym wodogłowiem 
wewnętrznym; hepatoblastoma o średnicy 5,0 cm) i niewydolność wielonarządową po urodzeniu nie podjęto 
leczenia przeciw-nowotworowego, ograniczono się jedynie do leczenia paliatywnego. Zgon nastąpił w 30 dobie 
życia, wśród objawów niewydolności oddechowo-krążeniowej.
 Słowa kluczowe: noworodek / zapłodnienie in vitro / craniopharyngioma / 
                   / hepatoblastoma /  
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The	 aetiology	 of	 cancer	 in	 children	 is	 multifactorial,	 and	
includes	both	genetic	and	environmental	factors.	The	association	
between	congenital	abnormalities	and	tumours	is	well-established	
[1,	 3].	 Certain	 constitutional	 chromosome	 abnormalities	
specifically	favour	tumours	occurring	in	the	foetal	and	neonatal	
periods	 [2].	 Other	 environmental	 associations	 include	 ionizing	








and	 liver	 tumours	 are	 among	 the	 most	 frequent	 neoplasms	
diagnosed	by	prenatal	ultrasound.	
Central	nervous	system	neoplasms	comprise	 the	fifth	most	
frequent	 group	 of	 neonatal	 tumours,	 as	 follows:	 astrocytomas,	
36.9%;	 medulloblastomas,	 16%;	 pineal	 region	 neoplasms,	




Primary	 liver	 tumours	 comprise	 approximately	 5%	 of	 all	




The	 number	 of	 children	 born	 as	 a	 result	 of	 advanced	
hormonal	therapy	for	ovulation	and	spermatogenesis	and	assisted	
reproductive	 technology	 (ART)	 has	 increased	 in	 recent	 years	
[8].	Reports	on	embryonal	tumours	of	the	CNS,	liver,	and	bone	






and	 a	 healthy	 37-year-old	 father	 with	 	 no	 family	 history	 of	
neoplasia.	 The	 mother	 had	 been	 treated	 for	 several	 years	 for	
infertility.	 The	 first	 IVF	 attempt	 resulted	 in	 a	 spontaneous	
abortion	at	8	weeks	gestation.	The	newborn	was	born	from	the	
second	 pregnancy,	 which	 was	 achieved	 with	 IVF	 and	 embryo	
transfer	 (ET)	 with	 intracytoplasmic	 sperm	 injection	 (ICSI).	
Before	 and	 during	 the	 ICSI	 procedure	 the	 mother	 was	 given	




At	 35	 weeks	 gestation ultrasound	 and	 MRI	 foetal	 scan	










The	 newborn	 required	 an	 incubator	 environment	 and	 passive	
oxygen	therapy.	
From	the	2nd	day	of	life,	an	exacerbated	jaundice	with	normal	
liver	 function	 tests.	 The	 neonate	 did	 not	 tolerate	 oral	 feeding	
and	developed	 significant	 abdominal	 distension.	An	 abdominal	
ultrasound	 revealed	 the	 presence	 of	 a	 solid,	 heterogeneous,	
well-delineated	tumour,	5.0cm	in	diameter,	affecting	the	III	and	
IV	 segments	with	 an	 irregular	hypoechogenic	 focus	 that	 likely	
represented	necrosis	within	the	tumour	(Figure	1B).	
A	 chest	 X-ray	 and	 heart	 ultrasound	 were	 normal.	A	 liver	
biopsy	was	not	attempted	at	the	request	of	the	parents.	
The	 severe	 general	 condition	 of	 the	 newborn	 and	 the	
progressive	cardio-respiratory	distress	were	contraindications	for	
chemotherapy.	The	newborn	died	on	the	30th	day	of	 life	due	to	
a	 generalized	 neoplastic	 process	with	 symptoms	 of	 respiratory	
and	 circulatory	 failure.	 The	 autopsy	 listed	 the	 direct	 cause	 of	
death	as	cerebellar	and	brainstem	herniation.	A	histopathologic	
examination	 confirmed	 the	 presence	 of	 two	 histologically	
different	tumours	(craniopharyngioma	and	hepatoblastoma).	
On	 gross	 examination,	 the	 craniopharyngioma	 occupied	
the	base	of	the	brain	and	presented	as	a	large,	15	x	12cm	cystic	
tumor.	 Histologically,	 squamous	 epithelium	 with	 a	 palisading	
arrangement	of	cells	at	the	periphery	of	the	cell	nest	was	noted.	
Masses	 of	 keratin	 and	 calcifications	were	 also	 present	 (Figure	
2A).		
The	hepatoblastoma	appeared	grossly	in	the	liver	as	a	well-
defined	 solid	 tumor,	 5cm	 in	 diameter,	 with	 areas	 of	 necrosis	







a	 hepatoblastoma)	 that	 have	 no	 biological	 link.	The	 published	




control	 study	 that	assessed	 the	 risk	of	children	with	congenital	
malformations	 developing	 cancer	 [3].	The	 report	 confirms	 that	
children	with	congenital	malformations	have	an	increased	risk	of	
various	malignancies.	Das	et	al,	 indicate	a	possible	association	
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As	 in	 our	 case,	 one	 of	 the	 patients	was	 not	 scheduled	 for	
surgery	 due	 to	 her	 serious	 condition,	 which	 is	 the	 method	 of	
choice	in	this	type	of	neoplasm	[10].	
Hepatoblastomas	 are	 rare	 in	 newborns	 born	 from	 IVF	
pregnancies	 [11].	 In	 our	 case,	 the	 hepatoblastoma	 was	 not	
diagnosed	 during	 the	 prenatal	 ultrasound	 examination.	 Moore	
et	al,	concluded	 	 that	majority	of	 tumours	with	a	mass	at	birth	
were	not	identified	on	antenatal	ultrasound	[2].	The	majority	of	
newborns	with	 hepatoblastomas	 are	 scheduled	 for	 surgery	 and	
chemotherapy	 [6,	 9];	 however,	 it	 should	 be	 emphasized	 that	











of	 332	 children	 from	 1254	 women	 who	 underwent	 IVF	 and	
observed	no	 cancer	 cases	 [13].	However,	 because	of	 the	 small	










clinical	 research,	 including	 long-term	 follow-up,	 is	 urgently	
required	to	evaluate	 the	prevalence	of	 imprinting	disorders	and	
cancers	 associated	 with	ART	 [14].	 Raimondi	 et	 al,	 conducted	
a	 meta-analysis	 on	 11	 cohort	 studies	 of	ART	 and	 subsequent	




Figure 1A. MRI axial post-contrast T1WI shows a large heterogeneous lesion 
with irregular enhancement. The lesion causes obstructive hydrocephalus involving 
the lateral ventricles. 
 
Figure 2A. Craniopharyngioma with characteristic palisading of tumor cells  
(HE stain, original magnification x200).  
 
Figure 1B. Abdominal ultrasound shows left liver lobe tumour, 5 cm in diameter. 
 
 
Figure 2B. Hepatoblastoma, classical morphology with few rosettes present  
(HE stain, original magnification x200). 
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the	 cohort	 of	 children	 born	 after	ART,	 updated	 record	 linkage	
for	 complete	 cancer	 cases	 identification,	 and	 calculation	 of	
standardized	 incidence	 ratios	 stratified	 by	 cause	 of	 infertility,	
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